CCI gives approval to FIL Capital Investments (Mauritius) II in Cipla Health
Cipla announced that FIL Capital Investments (Mauritius) II have informed the Company that they have received intimation from the Competition Commission of India (CCI) that the CCI has granted its approval with respect to, inter alia, the proposed investment by FIL Capital Investments (Mauritius) II in Cipla Health, subsidiary of the Company. The order of the CCI will be sent to FIL Capital Investments (Mauritius) II subsequently.The investment is still subject to, amongst other conditions precedent, approval from the Foreign Investment Promotion Board and the transfer of Company's consumer healthcare business to Cipla Health.
Powered by Capital Market - Live News
